Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells
Author:
Funder
Foundation for Science and Technology
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference73 articles.
1. A Comparison of Lorazepam, Diazepam, and Placebo for the Treatment of Out-of-Hospital Status Epilepticus;Alldredge;N. Engl. J. Med.,2001
2. Intranasal administration of carbamazepine to mice: A direct delivery pathway for brain targeting;Serralheiro;Eur. J. Pharm. Sci.,2014
3. Intranasal fosphenytoin: The promise of phosphate esters in nose-to-brain delivery of poorly soluble drugs;Pires;Int. J. Pharm.,2021
4. Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis;Costa;J. Control Release,2019
5. Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring;von Blomberg;CNS drugs,2020
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nano Lipid Carriers as a Promising Drug Delivery Carrier for Neurodegenerative Disorders - An Overview of Recent Advances;Recent Patents on Biotechnology;2024-03
2. Quality by design endorsed atorvastatin-loaded nanostructured lipid carriers embedded in pH-responsive gel for melanoma;Journal of Microencapsulation;2023-12-07
3. Breaking barriers: Intranasal delivery of brexpiprazole-nanostructured lipid carriers targets the brain for effective schizophrenia treatment;Journal of Drug Delivery Science and Technology;2023-12
4. Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery;Expert Opinion on Drug Delivery;2023-11-12
5. Brain targeting of drugs via intranasal route in conjunction with nanoparticle-based systems: an updated review;Journal of Nanoparticle Research;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3